Erythropoiesis in primary (idiopathic) osteomyelofibrosis: Quantification, PCNA-reactivity, and prognostic impact-Reference-Cited by-同舟云学术

Erythropoiesis in primary (idiopathic) osteomyelofibrosis: Quantification, PCNA-reactivity, and prognostic impact

Published:1994-05 Issue:1 Volume:46 Page:36-42
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Thiele Juergen,Windecker Roland,Kvasnicka Hans Michael,Titius Baerbel Ruth,Zankovich Rudolph,Fischer Robert

Publisher

Wiley

Subject

Hematology

Reference48 articles.

1. THE NATURAL HISTORY OF AGNOGENIC MYELOID METAPLASIA (AMM) AND A CRITICAL EVALUATION OF ITS RELATIONSHIP WITH THE MYELOPROLIFERATIVE SYNDROME

2. : Clinical and hematological aspects of chronic myelofibrosis. In (ed): “Myelofibrosis, Pathophysiology and Clinical Management.” New York: M. Dekker, 1985, pp 15–49.

3. Agnogenic myeloid metaplasia (AMM)—correlation of bone marrow lesions with laboratory data: A longitudinal clinicopathological study on 114 patients

4. Idiopathic myelofibrosis: A clinical study of 80 patients

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palliative splenic irradiation in primary and post PV/ET myelofibrosis: outcomes and toxicity of three radiation schedules;Hematology Reports;2009-05-04

2. Classification of Ph-Negative Chronic Myeloproliferative Disorders – Morphology as the Yardstick of Classification;Pathobiology;2007

3. The 2001 World Health Organization and Updated European Clinical and Pathological Criteria for the Diagnosis, Classification, and Staging of the Philadelphia Chromosome-Negative Chronic Myeloproliferative Disorders;Seminars in Thrombosis and Hemostasis;2006-06

4. Hematopathologic Findings in Chronic Idiopathic Myelofibrosis;Seminars in Oncology;2005-08

5. Chronic Myeloproliferative Disorders: A Pathologist’s View;Molecular Basis of Chronic Myeloproliferative Disorders;2004